Table 3.
Treatment, complications, and clinical outcome of the patients.
| Characteristic | Patients(n = 103) |
|---|---|
| Treatment | |
| Oxygen inhalation, n (%) | 41 (39.8%) |
| Invasive mechanic ventilation, n (%) | 62 (60.2%) |
| Discharged from ICU, n (%) | 1 (1.6%) |
| Died, n (%) | 47 (75.8%) |
| Remained in ICU, n (%) | 14 (22.5%) |
| Vasopressor, n (%) | 47 (45.6%) |
| Continuous renal replacement therapy, n (%) | 21 (20.4%) |
| Blood purification treatment, n (%) | 4 (3.9%) |
| Hydroxychloroquine, n (%) | 103 (100%) |
| Favipiravir, n (%) | 52 (50.5%) |
| Lopinavir/Ritonavir, n (%) | 40 (38.8%) |
| Steroids, n (%) | 63 (61.2%) |
| Tracheostomy, n (%) | 2 (1.9%) |
| Prone positioning, n (%) | 45 (43.6%) |
| Complications | |
| ARDS, n (%) | 63 (61.2%) |
| Acute kidney injury, n (%) | 31 (30.1%) |
| MODS, n (%) | 52 (50.5%) |
| Clinical outcome | |
| Median length of stay in ICU (IQR), days | |
| All patients | 7 (5–12) |
| Died | 7 (4–10) |
| Discharged | 6 (3.8–10.2) |
| Discharged from ICU, n (%) | 30 (29.1%) |
| Died, n (%) | 52 (50.5%) |
| Remained in ICU, n (%) | 21 (20.4%) |
ARDS: acute respiratory distress syndrome, MODS: multiple organ dysfunction 364 syndrome, ICU: intensive care unit. IQR: interquartile range.